CFRAs Ken Leon takes a look at investment banks that he thinks should benefit from increasing M&A activity.
Leon writes that a favorable economy, in which companies and private equity firms have plenty of cash on hand, as well as a benign political climate will boost M&A activity in this year. Cross-border transactions, which made up more than....More>>>
Investing in biotech and pharmaceuticals is always a bit of a wild card. The industry is often at the mercy of government regulators, and a clinical trial can always present unexpected challenges. When biotech and pharma stocks hit it big, however, its big news that often yields big returns. A lesser promoted biotech sector is the medical devices arena, which is hardly as sexy and....More>>>
The Q2 2017 earnings report for mid cap fabless semiconductor stock Marvell Technology Group Ltd (NASDAQ: MRVL) is scheduled for before the market opens on Tuesday (September 6th). We had Marvell Technology Groupin our SmallCap Network Elite Opportunity (SCN EO) portfolio back in 2013 becauseits fundamental and technical context appeared very attractive at the time and the company’s products....More>>>
Barclays analyst Jason Goldberg and team have “long been attracted to” shares of JPMorgan Chase (JPM), even before news that CEO Jamie Dimon spent $26 million dollars to buy shares in the mega-bank. With JPMorgan’s investor day coming up on Feb. 23, they explain why:
Photo: Michael Nagle/Bloomberg
We have long been attracted to the shares of JPMorgan, given....More>>>
The picks below are part of Kiplingers Personal Finances annual Best List, a roundup of the best values in all the areas we cover from funds, stocks and ETFs to credit cards and bank accounts to cars, college, kid stuff, phone plans, travel and health. Discover all our Best List picks here.
Kiplinger’s Best List, 2016 Best Mutual Funds You Can Invest in for $125 or Less....More>>>
American Express (AXP) is stuck between a rock and a hard place. As it battles MasterCard (MA) and Visa (V), American Express can either try to match their rewards–which will damage its returns–or stand its ground, which will make it hard to compete. Evercore ISI’s David Togut and team explain:
Credit card rewards continue to spiral skywards asAmerican....More>>>
This article is reprinted by permission from NextAvenue.org.
Money is the top cause of stress in the U.S., the American Psychological Association reports, and the leading driver of stress in the workplace, according to studies by the National Business Group on Health, Aon Hewitt, PwC and
You buy a stock for the long haul...
It's a great business. It trades at a great price. And you know its upside potential is huge.
For one reason or another, investors don't see the stock for what it is – a fantastic value.
So you take a medium- to large-siz
While most investors are trying to wrap their head around the soaring price of Bitcoin, I'm more focused on its underlying technology (blockchain) and its impact on the future of banking. Blockchain is here to stay and Bank of America (NYSE:BAC) is staking its claims.
On Dec. 20, 2017, the shares of Portola Pharmaceuticals (NASDAQ:PTLA), a bioscience specializing in the innovation and commercialization of drugs to treat blood disorders and cancers increased $4.13 to $55.12 (8.09% profits for traders) as of 2:01 pm EST. Previously, in part I and II r
Value investors get a bad rap. Sometimes, value investing is referred to as "cigar butt" investing, in that picking up cheap, undervalued stocks is equivalent to picking up mostly smoked cigars off of the sidewalk. A good friend and colleague of mine used to call me a "dumpster diver". Guilty.